Drug Database
Back to search

Ireland· IE-PA-PA0711/196/001

Mometasone 50 microgram/dose, Nasal spray, Suspension

A mometasone product containing mometasone furoate, registered in Ireland by Rowex Ltd. The same ATC class is registered in 13 of our 19 countries.

ATC R01AD09

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedMometasone 50 microgram/dose, Nasal s…ATCR01AD09REGISTER NO.IE-PA-PA0711/196/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mometasone furoateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mometasone is registered in 13 of 19 countries.

Countries holding a registration under ATC R01AD09 (mometasone), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose
Search mometasone products by name

Mometasone · ATC R01AD09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mometasone costs, country by country.

Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Mometasone · price per daily dose (0.2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Mometasone furoate
Manufacturer
Rowex Ltd
Country
Ireland (IE)
ATC code
R01AD09
ATC class
Mometasone
Defined daily dose
0.2 mg, N
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0711/196/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mometasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mometasone products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Asmanex Twisthaler, Elocon
  • Belgium · Asmanex Twisthaler, Elocom
  • Bulgaria · Блоктимо, Елоком
  • Cyprus · Elocon, Movesan
  • Czechia · Asmanex, Elocom
  • Germany · Allergo-Momelind, Asmanex Twisthaler
  • Denmark · Aphiahsone, Asmanex Twisthaler
  • Estonia · Breso, Elocon
  • Spain · Asmanex Twisthaler, Elocom
  • Finland · Asmanex Twisthaler, Demoson
  • France · Asmanex Twisthaler, Mometasone Arrow
  • United Kingdom (Northern Ireland) · Asmanex Twisthaler, Clarinaze Allergy Control
  • Greece · Asmanex Twisthaler, Elocon
  • Croatia · Elocom, Momanose
  • Hungary · Azocutan, Elocom
  • Iceland · Elocon, Kalmente
  • Italy · Arinit, Asmanex
  • Lithuania · Breso, Elocon
  • Luxembourg · Elocom, Monovo
  • Latvia · Breso, Elocon
  • Malta · Elocon, Nasonex
  • Netherlands · Elocon, Elocon Vet
  • Norway · Asmanex Twisthaler, Elocon
  • Poland · Aleric Spray, Edelan
  • Portugal · Asmanex Twisthaler, Desdek
  • Romania · Elocom, Furoat De Mometazonă Cipla
  • Sweden · Aphiahsone, Asmanex Twisthaler
  • Slovenia · Asmanex Twisthaler, Elocom
  • Slovakia · Asmanex, Elocom

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e95ae3ee-11bb-42ca-ae55-56d81a88fd41
GET /v1/drugs/e95ae3ee-11bb-42ca-ae55-56d81a88fd41?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nasal spray, suspension",
  "routes": [
    "Nasal use"
  ],
  "source": "hpra",
  "atc_all": [
    "R01AD",
    "R01AD09"
  ],
  "strength": null,
  "pa_number": "PA0711/196/001",
  "substances": [
    "Mometasone furoate"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "22/02/2013",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about mometasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console